marc thommen
senior technical development and operations
About
- Proven leadership skills as member of the EC, head of drug discovery chemistry, head of CMC at Polyphor and as product management head at Solvias AG. - Thorough understanding of the drug discovery and drug development process. - Built and led CMC team from 2016 onwards for the three clinical candidates of Polyphor (for details on products https://www.polyphor.com/), including CMC regulatory interactions with FDA and EMA. - Strong project management and marketing background. - P&L responsibilty for discovery operations and CRO product portfolio. - Creative team player with ability to motivate and maximize impact of all team members to synthesize solutions in time. - Goal focussed, going the extra mile. - Ability to rapidly adapt to new situations, adopt new challenges and perform. - Sound formation in chemistry incl. process chemistry, catalysis, analytics, solid state charcterization and formulation know-how (macrocycles, peptides, small molecules).
switzerland
basel
pharmaceuticals
technology platforms, dsm
Experience
senior technical development and operations manager
santhera pharmaceuticals
www.santhera.com for details on Santhera Pharmaceuticals
head cmc
polyphor ltd
* CMC responsibility for 3 clinical programs: 2 x clin. Phase 3 Balixafortide (CXCR4 inhibitor, oncology) and Murepavadin (p.a. selective antibiotic, OMPTA class) * clin. Phase 1b POL6014 (inhaled elastase inhibitor, CF) * 1 preclinical tox. program (novel broad spectrum antibiotic, OMPTA class)
senior technical development and operations
project manager
dsm
head of product management
solvias ag
product manager synthesis and catalysis
solvias ag
including outlicensing of catalysis technologies
project leader synthesis and catalysis
solvias ag
Development of robust industrial synthesis routes and catalytic processes; including tech transfer of processes to large volume manufacturing (cGMP) and chemo catalysis research activities
head of technology platforms
polyphor ltd
Polyphor is a Swiss Pharma company focusing on the discovery and development of macrocycle drugs addressing high unmet medical needs. Polyphor is a privately held company founded 1996 with about 100 employees, headquartered in Allschwil, near Basel. Polyphor's competitive edge is based on its two proprietary, innovative and complementary technologies, PEMfinder® and MacroFinder®, that provide fully synthetic, macrocyclic molecules. Macrocycles represent a new drug class complementary to the classical small molecules and large biopharmaceuticals. Polyphor leverages its unique and proprietary technologies to develop its own product portfolio and to pursue licensing and collaboration opportunities. For additional information, please visit www.polyphor.com
Education
stanford university
chemistry
With Prof. Dr. Barry M. Trost
university of bern
chemistry
With Prof. Dr. R. Keese
marc thommen's Contact Information
Phone
Find the Right Leads
Find Verified Contact Data
What LeadContact does well
Find verified emails, phone numbers, and decision-makers with 98% accuracy.
Find Leads
Find the right people by company, role, industry, location, and more.
925M+ professional profiles
Find Emails
Access verified email addresses for your target contacts.
657M+ emails
Find Phone Numbers
Get cross-validated phone data from multiple top sources.
239M+ phone numbers
More Accurate. Lower Cost.
Find contact data in 1 tool with 98% accuracy
LeadContact integrates leading enrichment tools to deliver more accurate contact data—without paying for each one.
Great conversations start with the right contact.
It’s time to find yours.